Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1050318328 | 10503183 | 28 | F | 201409 | 20160815 | 20141007 | 20160817 | EXP | CA-ROCHE-1446929 | ROCHE | 64.39 | YR | F | Y | 68.00000 | KG | 20160817 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1050318328 | 10503183 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | B20323,B20333,B2040,B2047,B2048,B20 | 125276 | 600 | MG | SOLUTION FOR INFUSION | ||||||
1050318328 | 10503183 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | U | B2048 | 0 | QD | ||||||||
1050318328 | 10503183 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | U | B2048 | 0 | QD | ||||||||
1050318328 | 10503183 | 4 | SS | DILTIAZEM. | DILTIAZEM | 1 | Unknown | 0 | |||||||||||
1050318328 | 10503183 | 5 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
1050318328 | 10503183 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
1050318328 | 10503183 | 7 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | SINCE 10 YEAR | 0 | ||||||||||
1050318328 | 10503183 | 8 | C | OMEPRAZOL | OMEPRAZOLE | 1 | Unknown | 0 | 20 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
1050318328 | 10503183 | 1 | Rheumatoid arthritis |
1050318328 | 10503183 | 2 | Blood cholesterol increased |
1050318328 | 10503183 | 4 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
1050318328 | 10503183 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
1050318328 | 10503183 | Arthralgia | |
1050318328 | 10503183 | Asthma | |
1050318328 | 10503183 | Back pain | |
1050318328 | 10503183 | Blood cholesterol increased | |
1050318328 | 10503183 | Blood pressure increased | |
1050318328 | 10503183 | Body temperature decreased | |
1050318328 | 10503183 | Bronchitis | |
1050318328 | 10503183 | Cough | |
1050318328 | 10503183 | Diarrhoea | |
1050318328 | 10503183 | Drug effect decreased | |
1050318328 | 10503183 | Eczema | |
1050318328 | 10503183 | Fall | |
1050318328 | 10503183 | Fatigue | |
1050318328 | 10503183 | Gastrooesophageal reflux disease | |
1050318328 | 10503183 | Heart rate increased | |
1050318328 | 10503183 | Hypertension | |
1050318328 | 10503183 | Hypotension | |
1050318328 | 10503183 | Infusion related reaction | |
1050318328 | 10503183 | Joint swelling | |
1050318328 | 10503183 | Muscle spasms | |
1050318328 | 10503183 | Muscular weakness | |
1050318328 | 10503183 | Nasopharyngitis | |
1050318328 | 10503183 | Oesophageal pain | |
1050318328 | 10503183 | Oral discomfort | |
1050318328 | 10503183 | Oropharyngeal pain | |
1050318328 | 10503183 | Oxygen saturation decreased | |
1050318328 | 10503183 | Pain | |
1050318328 | 10503183 | Pain in extremity | |
1050318328 | 10503183 | Peripheral swelling | |
1050318328 | 10503183 | Precancerous cells present | |
1050318328 | 10503183 | Seasonal allergy | |
1050318328 | 10503183 | Sinusitis | |
1050318328 | 10503183 | Skin swelling | |
1050318328 | 10503183 | Swelling | |
1050318328 | 10503183 | Vertigo | |
1050318328 | 10503183 | Weight decreased | |
1050318328 | 10503183 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
1050318328 | 10503183 | 1 | 20140805 | 0 |